These results are consistent with Individuals inside a 2022 trial extension on semaglutide (the generic name for Ozempic and Wegovy), which recommended that men and women who stopped taking two.4 mg weekly doses regained two-thirds on the weight they misplaced within 1 12 months of cessation. the knowledge delivered in this article is for educatio